Wednesday, October 23, 2019

Ivermectin - USA

›
Claim Construction (District of Delaware): Oct 22, 2019 Presently before the Court is the issue of claim construction of a term in U.S...
Saturday, October 12, 2019

Diclofenac - USA

›
On Oct 10, 2019, Federal Circuit affirmed district court’s decision which prohibited Actavis from marketing generic version of PENNSAID 2...
Thursday, October 10, 2019

Doxycycline - USA

›
On Oct 04, 2019 (unsealed opinion), Delaware court found infringement of formulation patents & rejected Sun’s argument that the paten...
Sunday, October 6, 2019

Erlotinib - USA

›
On Oct 04, 2019, Federal Circuit reversed PTAB’s decision & found method of treatment claims valid in Tarceva ® case. This appea...
Sunday, September 29, 2019

Dolutegravir - USA

›
Claim Construction (District of Delaware): Sep 26, 2019 This patent litigation dispute involves seven consolidated patent infringemen...
Saturday, September 28, 2019

Cyclosporine - USA

›
IPR decision: Sep 27, 2019 AIA Review # Filing Date Institution Date Petitioner Patent ...
Sunday, September 22, 2019

Weekly Patent Litigation Round-up

›
CJEU refuses UK High Court’s request for preliminary ruling on SPC applications based on third-party MAs, on account of referred question...
Saturday, September 21, 2019

Cinacalcet – USA

›
On Sep 18, 2019, Delaware court judge rejected Sun Pharma’s contention that its settlement with Amgen entitles Sun to launch its generic ...
Thursday, September 12, 2019

Oxycodone - USA

›
Claim Construction (District of Delaware): Sep 11, 2019 In these consolidated Hatch-Waxman patent litigation matters filed by Plainti...
Sunday, September 8, 2019

Esomeprazole & Naproxen

›
IPR decision: Sep 06, 2019 AIA Review # Filing Date Institution Decision Date Petitioner Pa...